Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
CPT: Pharmacometrics & Systems Pharmacology|November 12, 2025
Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular EventsAshraf Yassen, Friederike Kanefendt, Jochen Zisowsky, et al.Journal of the American College of Cardiology|May 30, 2015
Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statinsGregory G Schwartz, Markus Abt, Weihang Bao, et al.International Journal of Stroke : Official Journal of the International Stroke Society|May 29, 2019
Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUSShinichiro Uchiyama, Kazunori Toyoda, Kazuo Kitagawa, et al.European Stroke Journal|June 14, 2025
Location, size, and risk factors of incident covert brain infarcts in patients with acute non-cardioembolic ischemic stroke: PACIFIC-STROKE trialRobert G Hart, Eric E Smith, Angela Wang, et al.European Stroke Journal|February 26, 2025
Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRIGian Marco De Marchis, Anna Toebak, Tolga Dittrich, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 16, 2022
Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trialJackie Bosch, Lesly A Pearce, Mukul Sharma, et al.American Heart Journal|March 21, 2016
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II studyThomas J Povsic, Matthew T Roe, Erik Magnus Ohman, et al.Stroke|April 17, 2020
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS TrialGeorge Ntaios, Lesly A Pearce, Roland Veltkamp, et al.Stroke|September 28, 2019
Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XIBenjamin Georgi, Johanna Mielke, Mark Chaffin, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|July 31, 2024
Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment InitiationVinai Bhagirath, Tanya Kovalova, Jia Wang, et al.Pageof 5